No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr14:82224200-82224600 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
2 |
chr14:82231800-82232200 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
3 |
chr14:82231800-82233200 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
4 |
chr14:82231800-82234200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
5 |
chr14:82231800-82234400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
6 |
chr14:82231800-82235000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
7 |
chr14:82232000-82234200 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
8 |
chr14:82232200-82233000 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
9 |
chr14:82232200-82233800 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
10 |
chr14:82232200-82234200 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
11 |
chr14:82232200-82234200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
12 |
chr14:82232800-82233200 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
13 |
chr14:82232800-82234200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
14 |
chr14:82233000-82233600 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
15 |
chr14:82233000-82234000 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
16 |
chr14:82233000-82235000 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
17 |
chr14:82233600-82234600 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
18 |
chr14:82234200-82237200 |
Weak transcription |
Primary monocytes fromperipheralblood |
blood
|
19 |
chr14:82234200-82237800 |
Weak transcription |
Primary neutrophils fromperipheralblood |
blood
|
20 |
chr14:82234600-82234800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
21 |
chr14:82235000-82237000 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
22 |
chr14:82237000-82237200 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
23 |
chr14:82237200-82239800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
24 |
chr14:82237200-82239800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
25 |
chr14:82237800-82238200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
26 |
chr14:82237800-82239200 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
27 |
chr14:82238200-82238400 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
28 |
chr14:82238400-82238800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
29 |
chr14:82238800-82242000 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
30 |
chr14:82240200-82241000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
31 |
chr14:82241000-82248000 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
32 |
chr14:82243600-82243800 |
Enhancers |
Aorta |
Aorta
|
33 |
chr14:82243800-82250200 |
Weak transcription |
Aorta |
Aorta
|
34 |
chr14:82245600-82249800 |
ZNF genes & repeats |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
35 |
chr14:82247600-82249400 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
36 |
chr14:82247800-82248000 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
37 |
chr14:82247800-82248600 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
38 |
chr14:82248000-82248200 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
39 |
chr14:82248000-82248400 |
ZNF genes & repeats |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
40 |
chr14:82248400-82253400 |
Weak transcription |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
41 |
chr14:82248600-82248800 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
42 |
chr14:82248600-82248800 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
43 |
chr14:82248600-82249400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
44 |
chr14:82248800-82249000 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
45 |
chr14:82249000-82251200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
46 |
chr14:82249400-82249800 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
47 |
chr14:82249400-82249800 |
Enhancers |
Adipose Nuclei |
Adipose
|
48 |
chr14:82249800-82251200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
49 |
chr14:82250200-82250400 |
Enhancers |
Aorta |
Aorta
|
50 |
chr14:82253000-82253800 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|